Skip to main content
. 2022 Aug 7;12(8):730. doi: 10.3390/metabo12080730

Table 1.

Participant characteristics.

Continuous Variables Total (N = 950) Men (N = 391) Women (N = 559)
(Unit) Mean (SD) Mean (SD) Mean (SD)
Age (years) 52.6 (14.77) 52.4 (14.58) 52.7 (14.90)
BMI (kg/m2) 23.1 (3.63) 24.1 (3.51) 22.4 (3.54)
HbA1c (%) 5.7 (0.62) 5.7 (0.71) 5.7 (0.54)
Glycoalbumin (%) 14.6 (1.98) 14.4 (2.41) 14.7 (1.61)
Blood glucose (mg/dL) 96.3 (16.52) 99.8 (18.29) 93.9 (14.70)
Triglyceride (mg/dL) 98.2 (84.33) 125.2 (114.54) 79.4 (45.43)
Total cholesterol (mg/dL) 205.4 (34.27) 203.0 (34.17) 207.0 (34.27)
HDL cholesterol (mg/dL) 65.0 (16.66) 58.2 (15.00) 69.8 (16.08)
LDL cholesterol (mg/dL) 116.8 (29.79) 117.4 (29.34) 116.4 (30.11)
ALT (U/L) 20.9 (13.75) 26.5 (16.52) 17.0 (9.69)
AST (U/L) 21.8 (7.86) 23.8 (8.37) 20.5 (7.18)
γ-GTP (U/L) 33.2 (40.94) 49.1 (56.98) 22.1 (16.75)
Creatinine (mg/dL) 0.7 (0.55) 0.9 (0.74) 0.6 (0.33)
Urea nitrogen (mg/dL) 14.5 (4.50) 15.4 (4.52) 14.0 (4.40)
SBP (mmHg) 120.8 (16.88) 123.5 (16.65) 118.9 (16.79)
DBP (mmHg) 77.1 (11.20) 79.5 (11.48) 75.3 (10.67)
RR interval (ms) 866.9 (121.76) 885.9 (127.19) 853.7 (116.09)
CVRR (%) 3.4 (1.67) 3.4 (1.70) 3.4 (1.56)
SDNN (ms) 29.3 (14.56) 29.8 (15.7) 29.0 (13.76)
LF (ms2) 343.5 (522.26) 421.4 (625.19) 289.0 (428.32)
HF (ms2) 252.2 (340.90) 246.9 (364.04) 256.0 (324.03)
LF/HF (Ratio) 2.7 (3.99) 3.3 (4.73) 2.2 (3.32)
HR (bpm) 70.1 (10.15) 68.7 (10.23) 71.1 (9.98)
Categorical variables N (%) N (%) N (%)
Diabetes mellitus No 890 (93.9%) 361 (92.3%) 529 (95.0%)
Yes 58 (6.1%) 30 (7.7%) 28 (5.0%)
Hyperlipidemia No 778 (82.2%) 315 (81.0%) 463 (83.1%)
Yes 168 (17.8%) 74 (19.0%) 94 (16.9%)
High blood pressure No 711 (74.9%) 275 (70.3%) 436 (78.1%)
Yes 238 (25.1%) 116 (29.7%) 122 (21.9%)
Heart disease No 906 (95.5%) 366 (93.6%) 540 (96.8%)
Yes 43 (4.5%) 25 (6.4%) 18 (3.2%)
Gastric/Duodenal ulcer No 853 (89.9%) 342 (87.5%) 511 (91.6%)
Yes 96 (10.1%) 49 (12.5%) 47 (8.4%)
Antidiabetic medication use No 903 (95.1%) 367 (93.9%) 536 (95.9%)
Yes 47 (4.9%) 24 (6.1%) 23 (4.1%)
Antihyperlipidemic medication use No 846 (89.1%) 346 (88.5%) 500 (89.4%)
Yes 104 (10.9%) 45 (11.5%) 59 (10.6%)
Antihypertensive medication use No 728 (76.6%) 285 (72.9%) 443 (79.2%)
Yes 222 (23.4%) 106 (27.1%) 116 (20.8%)
Exercising (non-winter) No 732 (77.4%) 302 (77.6%) 430 (77.2%)
Yes 214 (22.6%) 87 (22.4%) 127 (22.8%)
Exercising (winter) No 731 (77.7%) 304 (78.6%) 427 (77.1%)
Yes 210 (22.3%) 83 (21.4%) 127 (22.9%)
Smoking No 596 (63.3%) 161 (41.6%) 435 (78.4%)
Current 161 (17.1%) 114 (29.5%) 47 (8.5%)
Previous 185 (19.6%) 112 (28.9%) 73 (13.2%)
Alcohol consumption No 444 (47.3%) 111 (28.6%) 333 (60.5%)
Current 456 (48.6%) 266 (68.6%) 190 (34.5%)
Previous 38 (4.1%) 11 (2.8%) 27 (4.9%)

Abbreviations: γ-GTP, γ-glutamyl transferase; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; bpm, beats per minute; CVRR, coefficient of variation of RR intervals; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HF, high-frequency component power; HR, heart rate; LDL, low-density lipoprotein; LF, low-frequency component power; SBP, systolic blood pressure; SD, standard deviation; SDNN, standard deviation of RR intervals.